Leading Corporate/M&A Partners Jake Robson and Adam Summerly to Join Morrison & Foerster’s Singapore Office

Jake Robson and Adam Summerly will join Morrison & Foerster as partners as the firm continues to expand its recently opened Singapore office. Messrs. Robson and Summerly, who have been based in Singapore for eight and 14 years respectively, are veteran deal advisers with substantial experience handling inbound, outbound and intra-regional transactions across South and Southeast Asia.

More >>

Tags:  Morrison & Foerster LLP | Singapore

Simpson Thacher Represents Underwriters in Connection with Oracle’s €2 Billion and $3 Billion Investment-Grade Note Offerings

Simpson Thacher represented the underwriters, led by BNP Paribas, Deutsche Bank AG, London Branch, and The Royal Bank of Scotland plc, in connection with Oracle Corporation’s first registered public offering of euro-denominated notes. Oracle Corporation offered €1.25 billion aggregate principal amount of 2.250% senior notes due 2021 and €750 million aggregate principal amount of 3.125% senior notes due 2025. The euro-denominated notes are listed on the New York Stock Exchange.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Amanda K. Jester Joins Waller as Partner

Waller, a nationally recognized law firm with offices in Austin, today announced that healthcare attorney Amanda K. Jester has joined its Austin office as partner. Formerly a partner at McDermott Will & Emery LLP, in Miami, Fla., Jester focuses her practice on advising and representing a vast range of healthcare clients including private equity funds, physician practices, hospital and health systems, ambulatory surgery centers, urgent care centers and pain management clinics.

More >>

Tags:  Waller Lansden Dortch & Davis, LLP | Austin

Dechert LLP Represents Onconova as it Announces Pricing of Initial Public Offering

Dechert LLP announced today that it advised Onconova Therapeutics, Inc. in an initial public offering of 5,166,667 shares of its common stock. The offering was announced today at $15.00 per share, before underwriting discounts. All of the shares of common stock are being offered by Onconova. In addition, Onconova has granted the underwriters a 30-day option to purchase up to an additional 775,000 shares of common stock at the same price to cover over-allotments, if any. The shares are now trading on The NASDAQ Global Market under the ticker symbol “ONTX.” The offering is expected to close on July 30, 2013, subject to customary closing conditions.

More >>

Tags:  Dechert LLP

Patton Boggs Advises Intezyne Technologies in Acquisition of Niiki Pharma

An M&A team from Patton Boggs LLP headed by Geoff Davis, a partner in the firm’s Washington DC office and Mark Goldschmidt, a partner in the firm’s Denver office recently represented Intezyne Technologies, a leader in the use of nanotechnology in the development of cancer treatment, in its strategic acquisition of target Niiki Pharma, significantly expanding Intezyne’s portfolio of cancer drugs and market valuation.

More >>

Tags:  Squire Patton Boggs